- Condition: Coronary Artery Disease
Intervention:
Sponsors: University of Saskatchewan; University of Saskatchewan
Enrolling by invitation - verified May 2012 - Conditions: Diabetes; Stroke; Obesity
Intervention:
Sponsors: Children's & Women's Health Centre of British Columbia; Children's & Women's Health Centre of British Columbia
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Tranexamic Acid; Drug: normal saline
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatoon Health Region
Active, not recruiting - verified May 2012 - Randomized Controlled Trial Comparing Postoperative Pain Following TAH With GA vs. Combined GA + SABCondition: Hysterectomy
Interventions: Drug: General Anesthesia + Spinal anesthesia combined; Drug: General Anesthesia (control group)
Sponsors: University of Saskatchewan; University of Saskatchewan
Not yet recruiting - verified January 2012 - Conditions: Diabetes Mellitus, Type 2; Hypercholesterolemia
Intervention: Other: BeneFlax - 38% secoisolariciresinol diglucoside (SDG)
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified February 2012 - Condition: Cancer of the Endometrium
Intervention:
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Not yet recruiting - verified November 2011 - Condition: Hypotension
Intervention: Device: Ultrasound
Sponsors: Saint John Regional Hospital; Saint John Regional Hospital
Recruiting - verified March 2012 - Condition: Advanced Rare Tumours
Interventions: Drug: Sunitinib; Drug: Temsirolimus
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Conditions: Coronary Artery Disease; Valvular Disease
Interventions: Procedure: Centrifugation and washing with saline; Procedure: Multiple-pass hemofiltration
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatoon Health Region
Enrolling by invitation - verified September 2011 - Condition: Atherosclerosis
Intervention:
Sponsors: Canadian Atherosclerosis Imaging Network; Canadian Atherosclerosis Imaging Network; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Condition: Asthma
Interventions: Drug: salbutamol; Drug: Placebo
Sponsors: University of Saskatchewan; University of Saskatchewan
Completed - verified May 2012 - Condition: Grief
Intervention: Behavioral: Writing Intervention
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatoon Health Region
Recruiting - verified August 2011 - Conditions: Postpartum Hemorrhage; Uterine Atony
Interventions: Drug: Oxytocin; Drug: Saline
Sponsors: University of Saskatchewan; University of Saskatchewan
Withdrawn - verified October 2011 - Condition: Bone Metastases
Interventions: Drug: Dexamethasone; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified March 2012 - Conditions: Oxidative Stress; Inflammation; Aging; Dementia; Pain
Intervention: Dietary Supplement: secoisolariciresinol diglucoside
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified October 2011 - Condition: Gestational Hypertension
Interventions: Procedure: Intervention is blood pressure management approach; Procedure: Intervention is blood pressure management approach.
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute
Recruiting - verified December 2011 - Condition: Melanoma
Interventions: Drug: rIL-21; Drug: Dacarbazine
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Condition: Recurrent Breast Cancer
Intervention: Drug: Foretinib
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Aging
Intervention:
Sponsors: University of Saskatchewan; University of Saskatchewan; Canadian Foundation for Women's Health
Completed - verified August 2011 - Conditions: Asthma; Allergic Rhinitis
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Allergy, Genes and Environment Network (AllerGen); Networks of Centres of Excellence (NCE)
Recruiting - verified November 2011 - Condition: Pain
Interventions: Drug: Lidocaine Infusion; Drug: Placebo
Sponsors: University of Saskatchewan; University of Saskatchewan
Recruiting - verified September 2011 - Conditions: Traumatic Memory; Posttraumatic Stress Disorder
Interventions: Drug: Propranolol Hydrochloride; Drug: Placebo
Sponsors: Mela, Mansfield, M.D.; Mela, Mansfield, M.D.
Recruiting - verified June 2011 - Conditions: Osteoporosis; Sarcopenia
Interventions: Dietary Supplement: creatine monohydrate; Dietary Supplement: sugar placebo
Sponsors: University of Saskatchewan; University of Saskatchewan
Active, not recruiting - verified September 2011 - Condition: Lung Cancer
Interventions: Drug: PF-00299804; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Opioid (morphine sulphate) in low dose
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Canadian Institutes of Health Research (CIHR); Nova Scotia Health Research Foundation; Atlantic Health Sciences Corporation
Active, not recruiting - verified December 2011 - Condition: Latent Tuberculosis Infection
Interventions: Drug: Isoniazid; Drug: Rifampin
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified June 2011 - Conditions: Pregnancy; Thrombophilia; Pregnancy Complications
Interventions: Drug: dalteparin sodium 5,000 IU prefilled syringes (antenatal); Drug: dalteparin sodium (after delivery - Control group)
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Condition: Head and Neck Cancer
Interventions: Biological: panitumumab; Drug: cisplatin; Radiation: 3-dimensional conformal radiation therapy; Radiation: accelerated radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified November 2011 - Conditions: Anxiety Disorder; Cognitive/Functional Effects; Colorectal Cancer; Depression; Fatigue; Psychosocial Effects of Cancer and Its Treatment; Sleep Disorders
Interventions: Behavioral: exercise intervention; Other: counseling intervention; Other: educational intervention; Other: laboratory biomarker analysis; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: fatigue assessment and management; Procedure: quality-of-life assessment
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Metabolic Syndrome
Interventions: Behavioral: Aerobic exercise training; Dietary Supplement: pulse based diet
Sponsors: University of Saskatchewan; University of Saskatchewan
Completed - verified September 2011 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: cediranib maleate; Drug: paclitaxel; Other: placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified March 2012 - Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus; Genetic: gene expression analysis; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Breast Cancer
Interventions: Drug: letrozole; Other: placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group; North Central Cancer Treatment Group; Southwestern Oncology Group (SWOG); Cancer and Leukemia Group B
Active, not recruiting - verified May 2012 - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Smoking
Interventions: Drug: Bupropion HCl ER; Drug: Placebo
Sponsors: McGill University; Mark Eisenberg; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec
Completed - verified May 2008 - Condition: Colorectal Cancer
Interventions: Biological: cetuximab; Drug: brivanib alaninate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Condition: Respiratory Insufficiency of Prematurity
Intervention: Other: Titration of oxygen therapy
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Conditions: Asthma; COPD
Intervention: Drug: salbutamol
Sponsors: University of Saskatchewan; University of Saskatchewan
Recruiting - verified May 2012 - Condition: Respiratory Insufficiency of Prematurity
Interventions: Device: nCPAP; Device: NIPPV
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Completed - verified March 2012 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: bortezomib; Drug: cyclophosphamide; Drug: prednisone; Drug: vincristine sulfate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Lymphoma
Interventions: Drug: bortezomib; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified June 2011 - Condition: Prostate Cancer
Interventions: Procedure: 7800 cGy/39 fractions in 8 weeks; Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified October 2011 - Conditions: Anxiety Disorder; Mood Disorder
Intervention:
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatoon Health Region
Completed - verified October 2011 - Condition: Venous Ulcer
Interventions: Device: Four-layer Bandage (Elastomeric); Device: Short-stretch Bandage (Non-elastomeric)
Sponsors: Queen's University; Queen's University; Canadian Institutes of Health Research (CIHR)
Completed - verified October 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; British Medical Research Council; Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified February 2012 - Condition: Apnea of Prematurity
Intervention: Drug: Caffeine citrate injection
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR); National Health and Medical Research Council, Australia
Active, not recruiting - verified March 2012 - Conditions: Osteoporosis; Osteopenia
Intervention: Dietary Supplement: exercise/soy isoflavone
Sponsors: University of Saskatchewan; University of Saskatchewan; Canadian Institutes of Health Research (CIHR)
Completed - verified September 2011 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: cisplatin; Drug: cytarabine; Drug: dexamethasone; Drug: gemcitabine hydrochloride; Other: clinical observation
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: CHOP regimen
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel; Drug: topotecan hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified August 2011 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Biological: epoetin alfa; Biological: filgrastim; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: paclitaxel
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; North Central Cancer Treatment Group; Southwest Oncology Group
Active, not recruiting - verified May 2012 - Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: prednisone; Drug: thalidomide
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Ovarian Cancer
Interventions: Drug: carboplatin; Drug: gemcitabine hydrochloride
Sponsors: National Cancer Institute (NCI); AGO Study Group; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified June 2011 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: paclitaxel; Drug: rebimastat
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified August 2011 - Condition: Sarcoma
Intervention: Drug: alvocidib
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate; Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: vinblastine; Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group
Completed - verified January 2012 - Condition: Lung Cancer
Interventions: Drug: marimastat; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified April 2012 - Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: dexamethasone; Drug: melphalan; Drug: prednisone
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Drug: octreotide acetate; Drug: tamoxifen citrate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011
 |
Join Clinical Trials by University in Saskatchewan |
